DNM1L and Alzheimer disease: Reduction of DRP1 maintained mitochondrial function, reduced β-amyloid and enhanced synaptic activity in the AD mouse model (Cho et al., 2009; Manczak et al., 2011; Gollihue and Rabchevsky, 2017).